Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees

Nearly nine months after slashing 25 percent of the company’s workforce, Iroko Pharmaceuticals is terminating more than 100 full-time and part-time employees.

Read More »

2-Drug HIV Treatment Filed for U.S., EU Approval

ViiV Healthcare made regulatory submissions to the EMA and the U.S. FDA for a single-tablet, two-drug regimen of dolutegravir (ViiV Healthcare) and rilpivirine (Janssen).

Read More »

The Best Defense is a Good Quality Offense

While data help manufacturers fix plant-floor problems and trace quality issues to their source, it also can prevent recalls. Why not proactively use data to attain an end-to-end view of operations so that product quality can be ensured while reducing recalls?

Read More »

Philips in deals with U.S. hospitals on use of its gene data platform for cancer research

Dutch healthcare technology company Philips said Thursday it had reached deals with New York’s Memorial Sloan Kettering Cancer Center (MSK) and Utah-based Intermountain Healthcare for them to use its genomics platform for cancer research and treatment.

Read More »

Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients

Roche announced U.S. FDA approval of the Ventana ALK (D5F3) CDx Assay as a companion diagnostic to identify ALK-positive non-small cell lung cancer (NSCLC) patients eligible for treatment with the Novartis drug Zykadia (ceritinib). The Ventana ALK (D5F3) Assay is the only immunohistochemistry (IHC) test approved by the FDA as a companion diagnostic for Zykadia.

Read More »

EU Approves Biogen’s Spinraza for SMA

Biogen Inc.’s Spinraza secured European Union approval to treat spinal muscular atrophy (SMA), a leading genetic cause of death in infants.

Read More »

Massachusetts’ Cellanyx Develops New Method to Culture Primary Prostate Cells

Things are looking bright for tiny startup biotech Cellanyx as the company has made headway on revolutionizing precision diagnostic test for prostate cancer.

Read More »

EU Approves Brineura for CLN2 Disease

The European Commission granted marketing authorization for BioMarin Pharmaceutical’s Brineura for the treatment of tripeptidyl peptidase 1 (TPP1) deficiency.

Read More »

7 Biotechs and Pharmas That Have the Potential to Double (or More)

Jon Ogg, writing for 24/7 Wall Street, looks at seven biopharma stocks that have the potential to double or more in value during 2017.

Read More »

Health Care Trends Impacting Organized Provider Groups

The white paper explores trends and market forces affecting organized provider groups (OPGs) and identifies opportunities for pharmaceutical manufacturers to partner with OPGs to develop mutually beneficial programs addressing areas of shared interest.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom